Graduating School 【 display / non-display 】
-
Kyushu University, Faculty of Science, Graduated
Graduate School 【 display / non-display 】
-
Kyushu University, Graduate School, Division of Natural Science, Doctor's Course, Completed
-
Kyushu University, Graduate School, Division of Natural Science, Master's Course, Completed
-
Kyushu University, Graduate School, Division of Natural Science, Doctor's Course, Completed
-
Kyushu University, Graduate School, Division of Natural Science, Master's Course, Completed
Campus Career 【 display / non-display 】
-
2023.04-2024.09Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Cognitive and Behavioral Medicine， Neurology and Neurological Science， Project Junior Associate Professor
-
2024.10-2025.06Institute of Science Tokyo， -， Institute of Integrated Research， NucleoTIDE and PepTIDE Drug Discovery Center， Project Junior Associate Professor
-
2025.07-NowInstitute of Science Tokyo， -， -， -， Junior Associate Professor
Published Papers & Misc 【 display / non-display 】
-
Joachim F. R. Van Guyse, Saed Abbasi,Kazuko Toh, Zlata Nagorna, Junjie Li, Anjaneyulu Dirisala, Sabina Quader, Satoshi Uchida, Kazunori Kataoka. Facile generation of heterotelechelic poly(2-oxazoline)s towards accelerated exploration of poly(2-oxazoline)-based nanomedicine Angewandte Chemie International Edition. 2024.04; ( DOI )
-
Miki Suzuki, Yuki Mochida, Mao Hori, Akimasa Hayashi, Kazuko Toh, Theofilus A. Tockary, Xueying Liu, Victor Marx, Hidetomo Yokoo, Kanjiro Miyata, Makoto Oba, and Satoshi Uchida. Poly(ethylene Glycol) (PEG)–OligoRNA Hybridization to mRNA Enables Fine-Tuned Polyplex PEGylation for Spleen-Targeted mRNA Delivery Small Science. 2024.02; ( DOI )
-
Masahiro Ohara, Tetsuya Nagata, Rintaro Iwata Hara, Kie Yoshida-Tanaka, Nozomi Toide, Kazunori Takagi, Kazuki Sato, Tomoya Takenaka, Masanori Nakakariya, Kenichi Miyata, Yusuke Maeda, Kazuko Toh, Takeshi Wada, Takanori Yokota. DNA/RNA heteroduplex technology with cationic oligopeptide reduces class-related adverse effects of nucleic acid drugs Molecular Therapy: Nucleic Acid. 2024; ( DOI )